{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:45:37Z","timestamp":1792568737594,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Biol."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11515-016-1424-0","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T04:05:53Z","timestamp":1476763553000},"page":"376-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities"],"prefix":"10.1007","volume":"11","author":[{"given":"Christopher M.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"issue":"1","key":"1424_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1152\/physrev.00017.2008","volume":"89","author":"C M Alberini","year":"2009","unstructured":"Alberini C M (2009). Transcription factors in long-term memory and synaptic plasticity. Physiol Rev, 89(1): 121\u2013145","journal-title":"Physiol Rev"},{"key":"1424_CR2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neubiorev.2015.06.012","volume":"56","author":"F Allain","year":"2015","unstructured":"Allain F, Minogianis E A, Roberts D C, Samaha A N (2015). How fast and how often: The pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev, 56: 166\u2013179","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"1424_CR3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pharmthera.2004.12.004","volume":"106","author":"S M Anderson","year":"2005","unstructured":"Anderson S M, Pierce R C (2005). Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther, 106(3): 389\u2013403","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1424_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","volume":"153","author":"MT Bardo","year":"2000","unstructured":"Bardo MT, Bevins R A (2000). Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl), 153(1): 31\u201343","journal-title":"Psychopharmacology (Berl)"},{"key":"1424_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-420118-7.00001-9","volume":"69","author":"P M Beardsley","year":"2014","unstructured":"Beardsley P M, Hauser K F (2014). Glial modulators as potential treatments of psychostimulant abuse. Adv Pharmacol, 69: 1\u201369","journal-title":"Adv Pharmacol"},{"key":"1424_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2010.04.010","volume":"637","author":"P M Beardsley","year":"2010","unstructured":"Beardsley P M, Shelton K L, Hendrick E, Johnson KW (2010). The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime-and stress-induced methamphetamine relapse. Eur J Pharmacol, 637(1\u20133): 102\u2013108","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1424_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/adb.12106","volume":"20","author":"R L Bell","year":"2015","unstructured":"Bell R L, Lopez M F, Cui C, Egli M, Johnson K W, Franklin K M, Becker H C (2015). Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. Addict Biol, 20(1): 38\u201342","journal-title":"Addict Biol"},{"issue":"3","key":"1424_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004850-198807000-00006","volume":"3","author":"A Bertolino","year":"1988","unstructured":"Bertolino A, Crippa D, di Dio S, Fichte K, Musmeci G, Porro V, Rapisarda V, Sastre-y-Hern\u00e1ndez M, Schratzer M (1988). Rolipram versus imipramine in inpatients with major, \u201cminor\u201d or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharmacol, 3(3): 245\u2013253","journal-title":"Int Clin Psychopharmacol"},{"key":"1424_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2014.00129","volume":"8","author":"Y A Blednov","year":"2014","unstructured":"Blednov Y A, Benavidez J M, Black M, Harris R A (2014). Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL\/6J mice. Front Neurosci, 8: 129","journal-title":"Front Neurosci"},{"issue":"4","key":"1424_CR10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.neuron.2012.09.040","volume":"76","author":"J P Britt","year":"2012","unstructured":"Britt J P, Benaliouad F, McDevitt R A, Stuber G D, Wise R A, Bonci A (2012). Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron, 76(4): 790\u2013803","journal-title":"Neuron"},{"issue":"11","key":"1424_CR11","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/nprot.2007.441","volume":"2","author":"W A Carlezon Jr","year":"2007","unstructured":"Carlezon W A Jr, Chartoff E H (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc, 2(11): 2987\u20132995","journal-title":"Nat Protoc"},{"issue":"2","key":"1424_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","volume":"407","author":"J A Cherry","year":"1999","unstructured":"Cherry J A, Davis R L (1999). Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol, 407(2): 287\u2013301","journal-title":"J Comp Neurol"},{"issue":"1","key":"1424_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-012-2944-1","volume":"227","author":"K L Conrad","year":"2013","unstructured":"Conrad K L, Louderback K M, Milano E J, Winder D G (2013). Assessment of the impact of pattern of cocaine dosing schedule during conditioning and reconditioning on magnitude of cocaine CPP, extinction, and reinstatement. Psychopharmacology (Berl), 227(1): 109\u2013116","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"1424_CR14","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1074\/jbc.R200029200","volume":"278","author":"M Conti","year":"2003","unstructured":"Conti M, Richter W, Mehats C, Livera G, Park J Y, Jin C (2003). Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem, 278(8): 5493\u20135496","journal-title":"J Biol Chem"},{"key":"1424_CR15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1042\/BST0331319","volume":"33","author":"D M Cooper","year":"2005","unstructured":"Cooper D M (2005). Compartmentalization of adenylate cyclase and cAMP signalling. Biochem Soc Trans, 33: 1319\u20131322","journal-title":"Biochem Soc Trans"},{"key":"1424_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-1-4939-0653-6_2","volume":"61","author":"J C Crabbe","year":"2014","unstructured":"Crabbe J C (2014). Rodent models of genetic contributions to motivation to abuse alcohol. Nebr Symp Motiv, 61: 5\u201329","journal-title":"Nebr Symp Motiv"},{"issue":"4","key":"1424_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pupt.2010.12.011","volume":"24","author":"Z Diamant","year":"2011","unstructured":"Diamant Z, Spina D (2011). PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease. Pulm Pharmacol Ther, 24(4): 353\u2013360","journal-title":"Pulm Pharmacol Ther"},{"key":"1424_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000118897","volume":"26","author":"W W H Fleischhacker","year":"1992","unstructured":"Fleischhacker W W H, Hinterhuber H, Bauer H, Pflug B, Berner P, Simhandl C, Wolf R, Gerlach W, Jaklitsch H, Sastre-y-Hern\u00e1ndez M, Schmeding-Wiegel H, Sperner-Unterweger B, Voet B, Schubert H (1992). A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology, 26(1\u20132): 59\u201364","journal-title":"Neuropsychobiology"},{"issue":"13","key":"1424_CR19","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00213-014-3852-3","volume":"232","author":"K M Franklin","year":"2015","unstructured":"Franklin K M, Hauser S R, Lasek A W, McClintick J, Ding Z M, McBride W J, Bell R L (2015). Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). Psychopharmacology (Berl), 232(13): 2251\u20132262","journal-title":"Psychopharmacology (Berl)"},{"key":"1424_CR20","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2147\/DDDT.S108115","volume":"10","author":"P Gisondi","year":"2016","unstructured":"Gisondi P, Girolomoni G (2016). Apremilast in the therapy of moderateto-severe chronic plaque psoriasis. Drug Des Devel Ther, 10: 1763\u20131770","journal-title":"Drug Des Devel Ther"},{"key":"1424_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.05.051","volume":"570","author":"A Gonz\u00e1lez-Cuello","year":"2007","unstructured":"Gonz\u00e1lez-Cuello A, S\u00e1nchez L, Hern\u00e1ndez J, Teresa Castells M, Victoria Milan\u00e9s M, Laorden M L (2007). Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart. Eur J Pharmacol, 570(1\u20133): 1\u20139","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1424_CR22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0166-2236(90)90104-I","volume":"13","author":"A M Graybiel","year":"1990","unstructured":"Graybiel A M (1990). Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci, 13(7): 244\u2013254","journal-title":"Trends Neurosci"},{"issue":"14","key":"1424_CR23","doi-asserted-by":"crossref","first-page":"R509","DOI":"10.1016\/S0960-9822(00)00593-5","volume":"10","author":"A M Graybiel","year":"2000","unstructured":"Graybiel A M (2000). The basal ganglia. Curr Biol, 10(14): R509\u2013R511","journal-title":"Curr Biol"},{"issue":"1","key":"1424_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.physbeh.2004.10.011","volume":"84","author":"J W Grimm","year":"2005","unstructured":"Grimm J W, Fyall A M, Osincup D P (2005). Incubation of sucrose craving: effects of reduced training and sucrose pre-loading. Physiol Behav, 84(1): 73\u201379","journal-title":"Physiol Behav"},{"issue":"6843","key":"1424_CR25","first-page":"141","volume":"412","author":"J W Grimm","year":"2001","unstructured":"Grimm J W, Hope B T, Wise R A, Shaham Y (2001). Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature, 412(6843): 141\u2013142","journal-title":"Incubation of cocaine craving after withdrawal. Nature"},{"issue":"16","key":"1424_CR26","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.bmcl.2014.06.002","volume":"24","author":"T J Hagen","year":"2014","unstructured":"Hagen T J, Mo X, Burgin A B, Fox D 3rd, Zhang Z, Gurney ME (2014). Discovery of triazines as selective PDE4B versus PDE4D inhibitors. Bioorg Med Chem Lett, 24(16): 4031\u20134034","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"1424_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-4328(00)00315-6","volume":"118","author":"M M Hamdy","year":"2001","unstructured":"Hamdy M M, Mamiya T, Noda Y, Sayed M, Assi A A, Gomaa A, Yamada K, Nabeshima T (2001). A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. Behav Brain Res, 118(1): 85\u201393","journal-title":"Behav Brain Res"},{"issue":"3","key":"1424_CR28","first-page":"291","volume":"21","author":"R T Hansen 3rd","year":"2015","unstructured":"Hansen R T 3rd, Zhang H T (2015). Phosphodiesterase-4 modulation as a potential therapeutic for cognitive loss in pathological and nonpathological aging: possibilities and pitfalls. Curr Pharm Des, 21(3): 291\u2013302","journal-title":"Curr Pharm Des"},{"key":"1424_CR29","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1054-3589(08)60924-2","volume":"42","author":"N Hiroi","year":"1998","unstructured":"Hiroi N, Nestler E J (1998). Nuclear memory: gene transcription and behavior. Adv Pharmacol, 42: 1037\u20131041","journal-title":"Adv Pharmacol"},{"issue":"4","key":"1424_CR30","doi-asserted-by":"crossref","first-page":"e60537","DOI":"10.1371\/journal.pone.0060537","volume":"8","author":"C C Horn","year":"2013","unstructured":"Horn C C, Kimball B A, Wang H, Kaus J, Dienel S, Nagy A, Gathright G R, Yates B J, Andrews P L (2013). Why can\u2019t rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS ONE, 8(4): e60537","journal-title":"PLoS ONE"},{"key":"1424_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/3-540-26573-2_2","volume":"168","author":"A C Howlett","year":"2005","unstructured":"Howlett A C (2005). Cannabinoid receptor signaling. Handb Exp Pharmacol, (168): 53\u201379","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"1424_CR32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-011-2290-8","volume":"218","author":"W Hu","year":"2011","unstructured":"Hu W, Lu T, Chen A, Huang Y, Hansen R, Chandler L J, Zhang H T (2011). Inhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology (Berl), 218(2): 331\u2013339","journal-title":"Psychopharmacology (Berl)"},{"key":"1424_CR33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuropharm.2013.04.031","volume":"76","author":"S Ikemoto","year":"2014","unstructured":"Ikemoto S, Bonci A (2014). Neurocircuitry of drug reward. Neuropharmacology, 76 Pt B: 329\u2013341","journal-title":"Neuropharmacology"},{"issue":"4","key":"1424_CR34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1369-1600.2011.00334.x","volume":"17","author":"Y Itzhak","year":"2012","unstructured":"Itzhak Y, Anderson K L (2012). Changes in the magnitude of drugunconditioned stimulus during conditioning modulate cocaineinduced place preference in mice. Addict Biol, 17(4): 706\u2013716","journal-title":"Addict Biol"},{"issue":"2","key":"1424_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(96)00479-7","volume":"312","author":"M Iyo","year":"1996","unstructured":"Iyo M, Bi Y, Hashimoto K, Inada T, Fukui S (1996). Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. Eur J Pharmacol, 312(2): 163\u2013170","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1424_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-009-1594-4","volume":"206","author":"A C Janes","year":"2009","unstructured":"Janes A C, Kantak K M, Cherry J A (2009). The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens. Psychopharmacology (Berl), 206(2): 177\u2013185","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"1424_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.07.050","volume":"525","author":"E M Johansson","year":"2012","unstructured":"Johansson E M, Reyes-Irisarri E, Mengod G (2012). Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain. Neurosci Lett, 525(1): 1\u20136","journal-title":"Neurosci Lett"},{"issue":"1","key":"1424_CR38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.physiol.66.032102.112534","volume":"66","author":"J A Kauer","year":"2004","unstructured":"Kauer J A (2004). Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol, 66(1): 447\u2013475","journal-title":"Annu Rev Physiol"},{"key":"1424_CR39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2006.05.014","volume":"404","author":"M Kimura","year":"2006","unstructured":"Kimura M, Tokumura M, Itoh T, Inoue O, Abe K (2006). Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxoneprecipitated morphine withdrawal in rats. Neurosci Lett, 404(1\u20132): 107\u2013111","journal-title":"Neurosci Lett"},{"key":"1424_CR40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lfs.2015.02.006","volume":"127","author":"S Kimura","year":"2015","unstructured":"Kimura S, Ohi Y, Haji A (2015). Blockade of phosphodiesterase 4 reverses morphine-induced ventilatory disturbance without loss of analgesia. Life Sci, 127: 32\u201338","journal-title":"Life Sci"},{"issue":"1","key":"1424_CR41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0091-3057(98)00154-3","volume":"62","author":"C M Knapp","year":"1999","unstructured":"Knapp C M, Foye M M, Ciraulo D A, Kornetsky C (1999). The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Pharmacol Biochem Behav, 62(1): 151\u2013158","journal-title":"Pharmacol Biochem Behav"},{"issue":"14","key":"1424_CR42","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0024-3205(01)01249-8","volume":"69","author":"C M Knapp","year":"2001","unstructured":"Knapp C M, Lee K, Foye M, Ciraulo D A, Kornetsky C (2001). Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward. Life Sci, 69(14): 1673\u20131682","journal-title":"Life Sci"},{"issue":"4","key":"1424_CR43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00213-011-2436-8","volume":"219","author":"M Kuroiwa","year":"2012","unstructured":"Kuroiwa M, Snyder G L, Shuto T, Fukuda A, Yanagawa Y, Benavides D R, Nairn A C, Bibb J A, Greengard P, Nishi A (2012). Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor\/ PKA\/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl), 219(4): 1065\u20131079","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"1424_CR44","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1017\/S1461145714000595","volume":"17","author":"M Lai","year":"2014","unstructured":"Lai M, Zhu H, Sun A, Zhuang D, Fu D, Chen W, Zhang H T, Zhou W (2014). The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats. Int J Neuropsychopharmacol, 17(9): 1397\u20131407","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"1424_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","volume":"59","author":"V Lakics","year":"2010","unstructured":"Lakics V, Karran E H, Boess F G (2010). Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology, 59(6): 367\u2013374","journal-title":"Neuropharmacology"},{"key":"1424_CR46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(01)03023-2","volume":"920","author":"S Lamontagne","year":"2001","unstructured":"Lamontagne S, Meadows E, Luk P, Normandin D, Muise E, Boulet L, Pon D J, Robichaud A, Robertson G S, Metters K M, Nantel F (2001). Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey. Brain Res, 920(1\u20132): 84\u201396","journal-title":"Brain Res"},{"issue":"10","key":"1424_CR47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1177\/0269881112447991","volume":"26","author":"S Liddie","year":"2012","unstructured":"Liddie S, Anderson K L, Paz A, Itzhak Y (2012). The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice. J Psychopharmacol, 26(10): 1375\u20131382","journal-title":"J Psychopharmacol"},{"issue":"4","key":"1424_CR48","doi-asserted-by":"crossref","first-page":"e0125130","DOI":"10.1371\/journal.pone.0125130","volume":"10","author":"Y W Lim","year":"2015","unstructured":"Lim Y W, Meyer N P, Shah A S, Budde M D, Stemper B D, Olsen C M (2015). Voluntary alcohol intake following blast exposure in a rat model of mild traumatic brain injury. PLoS ONE, 10(4): e0125130","journal-title":"PLoS ONE"},{"issue":"4","key":"1424_CR49","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/npp.2013.299","volume":"39","author":"X Liu","year":"2014","unstructured":"Liu X, Liu Y, Zhong P, Wilkinson B, Qi J, Olsen C M, Bayer K U, Liu Q S (2014). CaMKII activity in the ventral tegmental area gates cocaine-induced synaptic plasticity in the nucleus accumbens. Neuropsychopharmacology, 39(4): 989\u2013999","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"1424_CR50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.alcohol.2015.03.007","volume":"49","author":"M L Logrip","year":"2015","unstructured":"Logrip M L (2015). Phosphodiesterase regulation of alcohol drinking in rodents. Alcohol, 49(8): 795\u2013802","journal-title":"Alcohol"},{"issue":"7","key":"1424_CR51","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/npp.2014.20","volume":"39","author":"M L Logrip","year":"2014","unstructured":"Logrip M L, Vendruscolo L F, Schlosburg J E, Koob G F, Zorrilla E P (2014). Phosphodiesterase 10A regulates alcohol and saccharin self-administration in rats. Neuropsychopharmacology, 39(7): 1722\u20131731","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1424_CR52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuropharm.2004.06.027","volume":"47","author":"L Lu","year":"2004","unstructured":"Lu L, Grimm J W, Hope B T, Shaham Y (2004). Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology, 47(Suppl 1): 214\u2013226","journal-title":"Neuropharmacology"},{"issue":"3","key":"1424_CR53","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","volume":"109","author":"C Lugnier","year":"2006","unstructured":"Lugnier C (2006). Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther, 109(3): 366\u2013398","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1424_CR54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj3470571","volume":"347","author":"S J MacKenzie","year":"2000","unstructured":"MacKenzie S J, Houslay M D (2000). Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells. Biochem J, 347(Pt 2): 571\u2013578","journal-title":"Biochem J"},{"issue":"5","key":"1424_CR55","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bjp.0703912","volume":"132","author":"T Mamiya","year":"2001","unstructured":"Mamiya T, Noda Y, Ren X, Hamdy M, Furukawa S, Kameyama T, Yamada K, Nabeshima T (2001). Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor. Br J Pharmacol, 132(5): 1111\u20131117","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1424_CR56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/npp.2015.142","volume":"41","author":"J R Mantsch","year":"2016","unstructured":"Mantsch J R, Baker D A, Funk D, L\u00ea A D, Shaham Y (2016). Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress. Neuropsychopharmacology, 41(1): 335\u2013356","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1424_CR57","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/npp.2015.240","volume":"41","author":"A McGirr","year":"2016","unstructured":"McGirr A, Lipina T V, Mun H S, Georgiou J, Al-Amri A H, Ng E, Zhai D, Elliott C, Cameron R T, Mullins J G, Liu F, Baillie G S, Clapcote S J, Roder J C (2016). Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition. Neuropsychopharmacology, 41(4): 1080\u20131092","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1424_CR58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchemneu.2010.03.004","volume":"40","author":"F Mori","year":"2010","unstructured":"Mori F, P\u00e9rez-Torres S, De Caro R, Porzionato A, Macchi V, Beleta J, Gavald\u00e0 A, Palacios J M, Mengod G (2010). The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D. J Chem Neuroanat, 40(1): 36\u201342","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"1424_CR59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1254\/jjp.83.113","volume":"83","author":"T Mori","year":"2000","unstructured":"Mori T, Baba J, Ichimaru Y, Suzuki T (2000). Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice. Jpn J Pharmacol, 83(2): 113\u2013118","journal-title":"Jpn J Pharmacol"},{"issue":"14","key":"1424_CR60","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s00213-016-4323-9","volume":"233","author":"M J Muelbl","year":"2016","unstructured":"Muelbl M J, Nawarawong N N, Clancy P T, Nettesheim C E, Lim Y W, Olsen C M (2016). Responses to drugs of abuse and non-drug rewards in leptin deficient ob\/ob mice. Psychopharmacology (Berl), 233(14): 2799\u20132811","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"1424_CR61","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1517\/13543784.2015.1094054","volume":"24","author":"A M Mulhall","year":"2015","unstructured":"Mulhall A M, Droege C A, Ernst N E, Panos R J, Zafar M A (2015). Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs. Expert Opin Investig Drugs, 24(12): 1597\u20131611","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"1424_CR62","doi-asserted-by":"crossref","first-page":"a012005","DOI":"10.1101\/cshperspect.a012005","volume":"3","author":"J W Muschamp","year":"2013","unstructured":"Muschamp J W, Carlezon W A Jr (2013). Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation. Cold Spring Harb Perspect Med, 3(2): a012005","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"1424_CR63","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.bmcl.2009.04.121","volume":"19","author":"K Naganuma","year":"2009","unstructured":"Naganuma K, Omura A, Maekawara N, Saitoh M, Ohkawa N, Kubota T, Nagumo H, Kodama T, Takemura M, Ohtsuka Y, Nakamura J, Tsujita R, Kawasaki K, Yokoi H, Kawanishi M (2009). Discovery of selective PDE4B inhibitors. Bioorg Med Chem Lett, 19(12): 3174\u20133176","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"1424_CR64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.112.007419","volume":"66","author":"S S Negus","year":"2014","unstructured":"Negus S S, Miller L L (2014). Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev, 66(3): 869\u2013917","journal-title":"Pharmacol Rev"},{"key":"1424_CR65","volume-title":"Brain Res","author":"E J Nestler","year":"2015","unstructured":"Nestler E J (2015). Reflections on: \u201cA general role for adaptations in GProteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res"},{"issue":"42","key":"1424_CR66","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1523\/JNEUROSCI.2518-08.2008","volume":"28","author":"A Nishi","year":"2008","unstructured":"Nishi A, Kuroiwa M, Miller D B, O\u2019Callaghan J P, Bateup H S, Shuto T, Sotogaku N, Fukuda T, Heintz N, Greengard P, Snyder G L (2008). Distinct roles of PDE4 and PDE10A in the regulation of cAMP\/PKA signaling in the striatum. J Neurosci, 28(42): 10460\u201310471","journal-title":"J Neurosci"},{"key":"1424_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.08.002","volume":"620","author":"C N\u00fa\u00f1ez","year":"2009","unstructured":"N\u00fa\u00f1ez C, Gonz\u00e1lez-Cuello A, S\u00e1nchez L, Vargas M L, Milan\u00e9s M V, Laorden M L (2009). Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus. Eur J Pharmacol, 620(1\u20133): 1\u20138","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1424_CR68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","volume":"25","author":"J M O\u2019Donnell","year":"2004","unstructured":"O\u2019Donnell J M, Zhang H T (2004). Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci, 25(3): 158\u2013163","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"1424_CR69","doi-asserted-by":"crossref","first-page":"e15085","DOI":"10.1371\/journal.pone.0015085","volume":"5","author":"C M Olsen","year":"2010","unstructured":"Olsen C M, Childs D S, Stanwood G D, Winder D G (2010). Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5). PLoS ONE, 5(11): e15085","journal-title":"PLoS ONE"},{"issue":"1","key":"1424_CR70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-006-0388-1","volume":"187","author":"C M Olsen","year":"2006","unstructured":"Olsen C M, Winder D G (2006). A method for single-session cocaine self-administration in the mouse. Psychopharmacology (Berl), 187(1): 13\u201321","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"1424_CR71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coph.2012.02.016","volume":"12","author":"C P Page","year":"2012","unstructured":"Page C P, Spina D (2012). Selective PDE inhibitors as novel treatments for respiratory diseases. Curr Opin Pharmacol, 12(3): 275\u2013286","journal-title":"Curr Opin Pharmacol"},{"issue":"52","key":"1424_CR72","doi-asserted-by":"crossref","first-page":"14018","DOI":"10.1523\/JNEUROSCI.4035-08.2008","volume":"28","author":"B Pan","year":"2008","unstructured":"Pan B, Hillard C J, Liu Q S (2008). D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci, 28(52): 14018\u201314030","journal-title":"J Neurosci"},{"issue":"6","key":"1424_CR73","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1523\/JNEUROSCI.4033-07.2008","volume":"28","author":"B Pan","year":"2008","unstructured":"Pan B, Hillard C J, Liu Q S (2008). Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci, 28(6): 1385\u20131397","journal-title":"J Neurosci"},{"issue":"31","key":"1424_CR74","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1523\/JNEUROSCI.1040-11.2011","volume":"31","author":"B Pan","year":"2011","unstructured":"Pan B, Zhong P, Sun D, Liu Q S (2011). Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaineinduced synaptic plasticity and rewarding effects. J Neurosci, 31(31): 11244\u201311255","journal-title":"J Neurosci"},{"issue":"1","key":"1424_CR75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1139\/O10-138","volume":"89","author":"B P\u00e9rez-Cadah\u00eda","year":"2011","unstructured":"P\u00e9rez-Cadah\u00eda B, Drobic B, Davie J R (2011). Activation and function of immediate-early genes in the nervous system. Biochem Cell Biol, 89(1): 61\u201373","journal-title":"Biochem Cell Biol"},{"key":"1424_CR76","first-page":"349","volume":"20","author":"S P\u00e9rez-Torres","year":"2000","unstructured":"P\u00e9rez-Torres S, Mir\u00f3 X, Palacios J M, Cort\u00e9s R, Puigdom\u00e9nech P, Mengod G (2000). Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat, 20(3\u20134): 349\u2013374","journal-title":"Comparison with monkey and rat brain. J Chem Neuroanat"},{"issue":"2","key":"1424_CR77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","volume":"25","author":"R C Pierce","year":"1997","unstructured":"Pierce R C, Kalivas P W (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev, 25(2): 192\u2013216","journal-title":"Brain Res Brain Res Rev"},{"issue":"9","key":"1424_CR78","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14728222.2013.818656","volume":"17","author":"W Richter","year":"2013","unstructured":"Richter W, Menniti F S, Zhang H T, Conti M (2013). PDE4 as a target for cognition enhancement. Expert Opin Ther Targets, 17(9): 1011\u20131027","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"1424_CR79","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","volume":"110","author":"A Robichaud","year":"2002","unstructured":"Robichaud A, Stamatiou P B, Jin S L, Lachance N, MacDonald D, Lalibert\u00e9 F, Liu S, Huang Z, Conti M, Chan C C (2002). Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptormediated anesthesia, a behavioral correlate of emesis. J Clin Invest, 110(7): 1045\u20131052","journal-title":"J Clin Invest"},{"issue":"3","key":"1424_CR80","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","volume":"18","author":"T E Robinson","year":"1993","unstructured":"Robinson T E, Berridge K C (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev, 18(3): 247\u2013291","journal-title":"Brain Res Brain Res Rev"},{"issue":"1507","key":"1424_CR81","first-page":"3137","volume":"363","author":"T E Robinson","year":"2008","unstructured":"Robinson T E, Berridge K C (2008). Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci, 363(1507): 3137\u20133146","journal-title":"The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"1424_CR82","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pbb.2004.08.018","volume":"79","author":"Z A Rodd","year":"2004","unstructured":"Rodd Z A, Bell R L, Sable H J, Murphy J M, McBride W J (2004). Recent advances in animal models of alcohol craving and relapse. Pharmacol Biochem Behav, 79(3): 439\u2013450","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"1424_CR83","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FBP.0b013e3283536d04","volume":"23","author":"J A Schroeder","year":"2012","unstructured":"Schroeder J A, Ruta J D, Gordon J S, Rodrigues A S, Foote C C (2012). The phosphodiesterase inhibitor isobutylmethylxanthine attenuates behavioral sensitization to cocaine. Behav Pharmacol, 23(3): 310\u2013314","journal-title":"Behav Pharmacol"},{"key":"1424_CR84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","volume":"168","author":"Y Shaham","year":"2003","unstructured":"Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl), 168(1\u20132): 3\u201320","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"1424_CR85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-007-1014-6","volume":"197","author":"J A Siuciak","year":"2008","unstructured":"Siuciak J A, McCarthy S A, Chapin D S, Martin A N (2008). Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology (Berl), 197(1): 115\u2013126","journal-title":"Psychopharmacology (Berl)"},{"key":"1424_CR86","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2013.01.016","volume":"701","author":"S E Snider","year":"2013","unstructured":"Snider S E, Hendrick E S, Beardsley P M (2013). Glial cell modulators attenuate methamphetamine self-administration in the rat. Eur J Pharmacol, 701(1\u20133): 124\u2013130","journal-title":"Eur J Pharmacol"},{"key":"1424_CR87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2012.01.013","volume":"679","author":"S E Snider","year":"2012","unstructured":"Snider S E, Vunck S A, van den Oord E J, Adkins D E, McClay J L, Beardsley P M (2012). The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. Eur J Pharmacol, 679(1\u20133): 75\u201380","journal-title":"Eur J Pharmacol"},{"key":"1424_CR88","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/FBP.0b013e328349ab37","volume":"22","author":"I P Stolerman","year":"2011","unstructured":"Stolerman I P, Childs E, Ford M M, Grant K A (2011). Role of training dose in drug discrimination: a review. Behav Pharmacol, 22(5\u20136): 415\u2013429","journal-title":"Behav Pharmacol"},{"key":"1424_CR89","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2015.02.048","volume":"591","author":"A Sun","year":"2015","unstructured":"Sun A, Zhuang D, Zhu H, Lai M, Chen W, Liu H, Zhang F, Zhou W (2015). Decrease of phosphorylated CREB and ERK in nucleus accumbens is associated with the incubation of heroin seeking induced by cues after withdrawal. Neurosci Lett, 591: 166\u2013170","journal-title":"Neurosci Lett"},{"issue":"9","key":"1424_CR90","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.0953-816X.2004.03357.x","volume":"19","author":"B E Thompson","year":"2004","unstructured":"Thompson B E, Sachs B D, Kantak K M, Cherry J A (2004). The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice. Eur J Neurosci, 19(9): 2561\u20132568","journal-title":"Eur J Neurosci"},{"key":"1424_CR91","volume-title":"Curr Protoc Neurosci","author":"M Thomsen","year":"2005","unstructured":"Thomsen M, Caine S B (2005). Chronic intravenous drug selfadministration in rats and mice. Curr Protoc Neurosci, 32:9.20: 9.20.1\u20139.20.40"},{"key":"1424_CR92","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nlm.2013.08.012","volume":"108","author":"T P Todd","year":"2014","unstructured":"Todd T P, Vurbic D, Bouton M E (2014). Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning. Neurobiol Learn Mem, 108: 52\u201364","journal-title":"Neurobiol Learn Mem"},{"key":"1424_CR93","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","volume":"12","author":"T M Tzschentke","year":"2007","unstructured":"Tzschentke T M (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol, 12(3\u20134): 227\u2013462","journal-title":"Addict Biol"},{"issue":"3","key":"1424_CR94","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1381612820666140826115559","volume":"21","author":"Z Z Wang","year":"2015","unstructured":"Wang Z Z, Zhang Y, Zhang H T, Li Y F (2015). Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseases. Curr Pharm Des, 21(3): 303\u2013316","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1424_CR95","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1381612820666140826114412","volume":"21","author":"R T Wen","year":"2015","unstructured":"Wen R T, Feng W Y, Liang J H, Zhang H T (2015). Role of phosphodiesterase 4-mediated cyclic AMP signaling in pharmacotherapy for substance dependence. Curr Pharm Des, 21(3): 355\u2013364","journal-title":"Curr Pharm Des"},{"issue":"12","key":"1424_CR96","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1530-0277.2012.01845.x","volume":"36","author":"R T Wen","year":"2012","unstructured":"Wen R T, Zhang M, Qin WJ, Liu Q, Wang WP, Lawrence A J, Zhang H T, Liang J H (2012). The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcoholpreferring Fawn-Hooded rats. Alcohol Clin Exp Res, 36(12): 2157\u20132167","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"1424_CR97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2006.05.029","volume":"173","author":"Y Yan","year":"2006","unstructured":"Yan Y, Nitta A, Mizuno T, Nakajima A, Yamada K, Nabeshima T (2006). Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds. Behav Brain Res, 173(1): 39\u201346","journal-title":"Behav Brain Res"},{"key":"1424_CR98","volume-title":"Source Methods of Behavior Analysis in Neuroscience","author":"R Young","year":"2009","unstructured":"Young R (2009). Drug Discrimination. In: Buccafusco J J, editor. Source Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press\/Taylor & Francis","edition":"2"},{"issue":"14","key":"1424_CR99","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2174\/138161209788168092","volume":"15","author":"H T Zhang","year":"2009","unstructured":"Zhang H T (2009). Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr Pharm Des, 15(14): 1688\u20131698","journal-title":"Curr Pharm Des"},{"issue":"7","key":"1424_CR100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.npp.1301537","volume":"33","author":"H T Zhang","year":"2008","unstructured":"Zhang H T, Huang Y, Masood A, Stolinski L R, Li Y, Zhang L, Dlaboga D, Jin S L, Conti M, O\u2019Donnell J M (2008). Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology, 33(7): 1611\u20131623","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"1424_CR101","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/npp.2012.93","volume":"37","author":"P Zhong","year":"2012","unstructured":"Zhong P, Wang W, Yu F, Nazari M, Liu X, Liu Q S (2012). Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference. Neuropsychopharmacology, 37(11): 2377\u20132387","journal-title":"Neuropsychopharmacology"}],"container-title":["Frontiers in Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11515-016-1424-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11515-016-1424-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11515-016-1424-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:23:39Z","timestamp":1498353819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11515-016-1424-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1007\/s11515-016-1424-0","relation":{},"ISSN":["1674-7984","1674-7992"],"issn-type":[{"value":"1674-7984","type":"print"},{"value":"1674-7992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}